BA Study of IMP4297 (20mg vs 10mg) in Healthy Male Subjects
Clinical trial NCT04351165 · COMPLETED
Trial details
- NCT number
- NCT04351165
- Sponsor
- Impact Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-29
- Primary completion
- 2021-02-11
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.